List/Grid

Miltenyi Biomedicine stellt die Primäranalyse der zulassungsrelevanten DALY-2-EU-Studie zur Zweitlinientherapie des rezidivierten/refraktären großzelligen B-Zell-Lymphoms auf der 67. Jahrestagung der American Society of Hematology (ASH) vor

  • Die Ergebnisse der DALY 2–EU–Studie zeigen, dass Zamtocabtagen Autoleucel (Zamto–cel) bei Patienten mit rezidiviertem/refraktärem großzelligem... More >>

À l’occasion de la 67e réunion annuelle de l’American Society of Hematology (ASH), Miltenyi Biomedicine présente l’analyse primaire de l’essai pivot DALY 2-EU pour le traitement de seconde ligne du lymphome à grandes cellules B en rechute ou réfractaire

  • Les résultats de l’essai DALY 2–EU révèlent que le zamtocabtagene autoleucel (zamto–cel) présente une supériorité... More >>

Miltenyi Biomedicine divulga análise primária do estudo principal do DALY 2-EU para linfoma de células B grandes recidivante/refratário de segunda linha na 67ª Reunião Anual da Sociedade Americana de Hematologia (ASH)

  • Os resultados do DALY 2–UE mostram que o autoleucel de zamtocabtageno (zamto–cel) demonstrou superioridade clinicamente significativa em relação à... More >>

Cochin Shipyard to build next-generation electric TRAnsverse tugs for Svitzer

Cochin, India and Copenhagen, Denmark – 8 December 2025. Svitzer, a leading global towage provider, and Cochin Shipyard Limited (CSL), India’s largest public sector shipyard, have signed a... More >>

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

  • DALY 2–EU results show zamtocabtagene autoleucel (zamto–cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B–cell lymphoma (r/r... More >>

A Moonup Technology firma parceria com a Shelly, líder europeia em casas inteligentes, para apresentar um ecossistema completo de edifícios inteligentes na Taipei Building Show de 2025

TAIPEI, Taiwan, Dec. 06, 2025 (GLOBE NEWSWIRE) — A Moonup Technology Co., Ltd., parceira de operações em Taiwan da Shelly (Shelly Group), líder europeia em casas inteligentes, anunciou sua participação de destaque na Taipei... More >>

Moonup Technology geht Partnerschaft mit dem europäischen Smart-Home-Marktführer Shelly ein, um auf der Taipei Building Show 2025 ein umfassendes Smart-Building-Ökosystem zu präsentieren

TAIPEI, Taiwan, Dec. 06, 2025 (GLOBE NEWSWIRE) — Moonup Technology Co., Ltd., der taiwanesische Partner des europäischen Smart–Home–Marktführers Shelly (Shelly Group), gab seine bedeutende Teilnahme an der Taipei Building Show 2025... More >>

Moonup Technology s’associe à Shelly, le leader européen de la maison intelligente, pour présenter un écosystème complet de bâtiments intelligents au Taipei Building Show 2025

TAIPEI, Taïwan, 06 déc. 2025 (GLOBE NEWSWIRE) — Moonup Technology Co., Ltd., partenaire opérationnel taïwanais du leader européen de la maison intelligente Shelly (Shelly Group), a annoncé sa participation majeure au salon... More >>

MRX DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Marex Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action – MRX

NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5,... More >>

MLTX IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action – MLTX

NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10,... More >>

1 / 58212345678910Next »